Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blase

Showing results (401-410 of 466) with videos related to

Pageof 47
Sort By:
Investigational New Drugs|May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II ConsortiumManish R Sharma, Kristen Wroblewski, Blase N Polite, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 16, 2019
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban SettingLeslie R Carnahan, Lindsey Jones, Katherine C Brewer, et al.
Heart Rhythm|July 31, 2018
Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apneaJonathan P Piccini, Sean D Pokorney, Kevin J Anstrom, et al.
Chemical Biology & Drug Design|February 12, 2009
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic dispositionMijoon Lee, Giuseppe Celenza, Bill Boggess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2015
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and CilengitidePeter H O'Donnell, Sanja Karovic, Theodore G Karrison, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Cancer Research|February 26, 2017
Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate CancerJeffrey D Thomas, Charles G Longen, Halley M Oyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group BBlase N Polite, Constance Cirrincione, Gini F Fleming, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Nature Communications|February 27, 2024
Disentangling the multiorbital contributions of excitons by photoemission exciton tomographyWiebke Bennecke, Andreas Windischbacher, David Schmitt, et al.
Pageof 47

Showing results (401-410 of 466) with videos related to

Sort By:
Pageof 47
Investigational New Drugs|May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II ConsortiumManish R Sharma, Kristen Wroblewski, Blase N Polite, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 16, 2019
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban SettingLeslie R Carnahan, Lindsey Jones, Katherine C Brewer, et al.
Heart Rhythm|July 31, 2018
Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apneaJonathan P Piccini, Sean D Pokorney, Kevin J Anstrom, et al.
Chemical Biology & Drug Design|February 12, 2009
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic dispositionMijoon Lee, Giuseppe Celenza, Bill Boggess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2015
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and CilengitidePeter H O'Donnell, Sanja Karovic, Theodore G Karrison, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Cancer Research|February 26, 2017
Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate CancerJeffrey D Thomas, Charles G Longen, Halley M Oyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group BBlase N Polite, Constance Cirrincione, Gini F Fleming, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Nature Communications|February 27, 2024
Disentangling the multiorbital contributions of excitons by photoemission exciton tomographyWiebke Bennecke, Andreas Windischbacher, David Schmitt, et al.
Pageof 47